MOONLAKE IMMUNO (MLTX)
(Delayed Data from NSDQ)
$8.66 USD
+0.23 (2.73%)
Updated Oct 6, 2025 04:00 PM ET
After-Market: $8.77 +0.11 (1.27%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MLTX 8.66 +0.23(2.73%)
Will MLTX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for MLTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MLTX
MLTX Stock Gains 18% as Merck Reportedly Eyes Buyout
Wall Street Analysts Think MOONLAKE IMMUNO (MLTX) Could Surge 106.62%: Read This Before Placing a Bet
MLTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MLTX
Top 3 Health Care Stocks That Are Preparing To Pump In Q4
LifeSci Capital Reaffirms Their Buy Rating on MoonLake Immunotherapeutics (MLTX)
Is MLTX building bearish momentum? 1,2,3 Retracement Bearish shows up after soaring 13.0%
Unusually active option classes on open October 3rd
Unusually active option classes on open October 3rd